HomeABDX • LON
Abingdon Health PLC
GBX 9.38
Sep 27, 5:30:00 PM GMT+1 · GBX · LON · Disclaimer
StockGB listed security
Previous close
GBX 9.25
Day range
GBX 9.10 - GBX 9.38
Year range
GBX 6.50 - GBX 14.00
Market cap
18.15M GBP
Avg Volume
93.33K
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
(GBP)Dec 2023Y/Y change
Revenue
1.20M116.92%
Operating expense
1.37M-2.77%
Net income
-602.50K50.23%
Net profit margin
-50.0077.05%
Earnings per share
——
EBITDA
-589.50K46.46%
Effective tax rate
1.23%—
Total assets
Total liabilities
(GBP)Dec 2023Y/Y change
Cash and short-term investments
2.00M-55.10%
Total assets
4.82M-31.92%
Total liabilities
3.01M-1.86%
Total equity
1.81M—
Shares outstanding
304.03M—
Price to book
9.25—
Return on assets
-37.95%—
Return on capital
-64.85%—
Net change in cash
(GBP)Dec 2023Y/Y change
Net income
-602.50K50.23%
Cash from operations
-599.50K-161.02%
Cash from investing
2.00K115.38%
Cash from financing
-21.50K-137.72%
Net change in cash
-619.00K-160.30%
Free cash flow
-331.62K49.86%
About
Abingdon Health is a British manufacturer of lateral flow assay diagnostic tests, sometimes called rapid tests, lateral flow immunoassays, lateral flow tests or quick tests. Since its formation in 2008, Abingdon Health has developed and manufactured lateral flow rapid tests across multiple industries. Headquartered in York, UK, with an additional office in Doncaster, UK. Wikipedia
Founded
Jan 1, 2008
Employees
84
Search
Clear search
Close search
Google apps
Main menu